A new article summarizes treatment options for women with recurrent ovarian cancer. The article includes information about when to treat a recurrence, what agents are available and the goals of therapy.
Read the full article here
Related Topics
KVIA-TV ABC-7 Features OCRA-Funded Research Developing Nanotechnology for Ovarian Cancer Detection
KVIA-TV ABC-7 News El Paso recently spotlighted the groundbreaking work of OCRA-funded researcher Daniel Heller, PhD of Memorial Sloan Kettering Cancer Center, whose research lab is working to develop a … Continued
Researchers Discover Potential Therapeutic Targets for Low-Grade Serous Ovarian Cancer
Scientists have identified sixteen potential therapeutic targets in low-grade serous ovarian cancer by studying proteins at the molecular level, with results published on August 11, 2025, in the journal Cancer … Continued
OCRA Sponsors NCCN 2025 Guidelines for Cervical Cancer Patients
This article was updated in May 2025 to reflect NCCN’s release of the 2025 Guidelines for Cervical Cancer Patients. OCRA is a proud sponsor of 2025 Cervical Cancer Updates. We … Continued